[{"Assets_0_Q3_USD":158273000.0,"CommonStockSharesOutstanding_0_Q3_shares":22566940.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-25664000.0,"NetIncomeLoss_1_Q3_USD":-15087000.0,"NetIncomeLoss_3_Q3_USD":-34601000.0,"StockholdersEquity_0_Q3_USD":146203000.0,"Ticker":"MIRM","CIK":"1759425","name":"MIRUM PHARMACEUTICALS, INC.","OfficialName":"Mirum Pharmaceuticals Inc. Common Stock","form":"10-Q","period":"20190930","fy":"2019.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"824673616.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20191106"}]